|
Established in 2004 with leadership gifts from James E. T. Hopkins, Janie Elizabeth Bailey and her husband Michael Musgrave, and an additional 10 members of the Hopkins family, including John L. Clark, whose bequest initiated the professorship in 1998.
|
JAMES E. T. HOPKINS, A&S 1937, SOM 1941, is the great-great nephew of Johns Hopkins. He left his surgical practice at Hopkins Hospital in 1942 to volunteer for military duty in the Pacific during World War II in the Army Medical Corps. Dr. Hopkins joined a unit that became known as Merrill's Marauders and received numerous honors, including the Bronze Star and the Presidential Unit Citation, for his efforts to provide medical care to the wounded behind enemy lines. After the war, Dr. Hopkins authored Spearhead: The Complete History of Merrill's Marauder Rangers. He retired from private thoracic surgery practice in Baltimore in 1989.
JANIE ELIZABETH (LIZA) BAILEY is the great-great-great niece of Johns Hopkins. She worked on Wall Street for 30 years, and for the last 20 years in mergers and acquisitions at Credit Suisse First Boston, from which she retired in 2004. Ms. Bailey is co-founder of GlobeVest Partners, a private equity international fund of funds. MICHAEL MUSGRAVE is a faculty member of the Julliard School of New York City. He was recently named an honorary Fellow of the Royal College of Music. Dr. Musgrave is a leading authority on German music of the 19th and 20th centuries and has authored and edited eight books on Brahms and related subjects.
|
CHI VAN DANG, SOM 1982, is the inaugural Johns Hopkins Family Professor of Oncology Research. He is Vice Dean for Research at Hopkins School of Medicine and oversees the Institute for Cell Engineering. A professor of cell biology, medicine, oncology, and pathology, Dr. Dang holds a joint appointment in Molecular Biology and Genetics. His research has led to a deeper understanding of the MYC cancer gene, which is a central switch in many different cancers. Dr. Dang is senior editor of Cancer Research and serves on editorial boards of Current Cancer Therapy Reviews, Drug Discovery Today, Journal of Clinical Investigation, and Neoplasia.
|
|